SEC Form 4
Colgate-Palmolive Company (CL) insider trading
In the 12 months to Oct 24, 2026, 8 CL insiders reported open-market sales of $57.1M across 13 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $57.1M
- 13 filings · 8 insiders
- Open-market purchases
- $0
- 0 filings
Who traded CL, and when
- Sale
CL daily close from Oct 24, 2025 to Oct 23, 2026, between $74.98 and $99.14, last $94.04. 13 sale and 0 purchase filings by 8 insiders, marked at their filing dates. Noel R. Wallace, Chairman, President & CEO: sold $34.0M across 2 filings, first filed Feb 6, 2026, last Aug 6, 2026. Stanley J. Sutula III, Chief Financial Officer: sold $9.2M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. Panagiotis Tsourapas, COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin: sold $5.7M across 2 filings, first filed Feb 13, 2026, last Aug 26, 2026. Sally Massey, Chief Human Resources Officer → Chief People Officer: sold $2.4M across 3 filings, first filed Nov 24, 2025, last May 11, 2026. Jennifer Daniels, CLO and Secretary: sold $2.1M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. John Hazlin, Chief Growth Officer: sold $2.0M across 1 filing, first filed Feb 12, 2026, last Feb 12, 2026. 2 others: sold $1.8M across 3 filings, first filed Feb 10, 2026, last Aug 7, 2026.
Largest mark · tap a row for others
Noel R. Wallace · Chairman, President & CEO
Sale $29,698,617
322,042 shares at $92.22 avg
Filed Aug 6, 2026 · traded Aug 4
Close on filing date $93.00
Noel R. Wallace · Chairman, President & CEO
Chairman, President & CEO
$34.0M soldStanley J. Sutula III · Chief Financial Officer
Chief Financial Officer
$9.2M soldPanagiotis Tsourapas · COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin
COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin
$5.7M soldSally Massey · Chief Human Resources Officer → Chief People Officer
Chief Human Resources Officer → Chief People Officer
$2.4M soldJennifer Daniels · CLO and Secretary
CLO and Secretary
$2.1M soldJohn Hazlin · Chief Growth Officer
Chief Growth Officer
$2.0M sold2 others
Combined, one mark per week
$1.8M soldHas the Colgate-Palmolive Company's CEO sold stock?
Yes. Noel R. Wallace (CEO) sold 367,610 shares ($34.0M) between Feb 2026 and Aug 2026.
Open-market trades
13 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Noel R. Wallace | Chairman, President & CEO | $34.0M | — | 2 | — | |
| Stanley J. Sutula III | Chief Financial Officer | $9.2M | — | 1 | — | |
| Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin | $5.7M | — | 2 | — | |
| Sally Massey | Chief Human Resources Officer → Chief People Officer | $2.4M | — | 3 | — | |
| Jennifer Daniels | CLO and Secretary | $2.1M | — | 1 | — | |
| John Hazlin | Chief Growth Officer | $2.0M | — | 1 | — | |
| Gregory Malcolm | EVP and Controller | $1.4M | — | 2 | — | |
| John T. Cahill | Director | $389.4K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 10,000 | $92.05 | $920.5K | 64,901 | |
traded | John T. Cahill Director | Sale | 4,170 | $93.37 | $389.4K | 28,373 | |
traded | Noel R. Wallace Chairman, President & CEO | Sale | 322,042 | $92.22 | $29.7M | 362,231 | |
traded | Gregory Malcolm EVP and Controller | Sale | 2,300 | $88.44 | $203.4K | 13,598 | |
traded | Sally Massey Chief People Officer | Sale | 8,599 | $87.41 | $751.6K | 13,785 | |
traded | Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin | Sale | 50,000 | $95.57 | $4.8M | 10,415 | |
traded | John Hazlin Chief Growth Officer | Sale | 20,989 | $94.25 | $2.0M | 17,645 | |
traded | Gregory Malcolm EVP and Controller | Sale | 12,747 | $94.91 | $1.2M | 11,879 | |
traded | Sally Massey Chief Human Resources Officer | Sale | 15,851 | $95.03 | $1.5M | 13,751 | |
traded | Noel R. Wallace Chairman, President & CEO | Sale | 45,568 | $93.91 | $4.3M | 293,188 | |
traded | Jennifer Daniels CLO and Secretary | Sale | 22,000 | $94.34 | $2.1M | 76,406 | |
traded | Stanley J. Sutula III Chief Financial Officer | Sale | 97,843 | $94.27 | $9.2M | 55,310 | |
traded | Sally Massey Chief Human Resources Officer | Sale | 1,237 | $80.89 | $100.1K | 13,751 |
GET /stocks/filings/vX/form-4?tickers=CL&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CL"
],
"issuer_cik": "0000021665",
"owner_cik": "0001576945",
"accession_number": "0001225208-26-007329",
"form_type": "4",
"filing_date": "2026-08-26",
"period_of_report": "2026-08-24",
"issuer_name": "COLGATE PALMOLIVE CO",
"issuer_trading_symbol": "CL",
"owner_name": "Tsourapas Panagiotis",
"is_officer": true,
"officer_title": "COO, CD, EMEA, APac, Skin",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-24",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 92.0477,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 64901,
"transaction_value": 920477.0000000001,
"direct_or_indirect": "I",
"nature_of_ownership": "By Trust",
"footnotes": [
{
"id": "F1",
"description": "Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "This amount includes 12,661 shares that were previously reported as directly beneficially owned."
}
]
},
{
"tickers": [
"CL"
],
"issuer_cik": "0000021665",
"owner_cik": "0001197000",
"accession_number": "0001225208-26-007035",
"form_type": "4",
"filing_date": "2026-08-07",
"period_of_report": "2026-08-06",
"issuer_name": "COLGATE PALMOLIVE CO",
"issuer_trading_symbol": "CL",
"owner_name": "CAHILL JOHN T",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-06",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 4170,
"transaction_price_per_share": 93.3712,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 28373,
"transaction_value": 389357.904,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan."
},
{
"id": "F3",
"description": "Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 82 records
- Option exercises10 records
- Tax withholding36 records
- Grants and awards36 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.